BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35306154)

  • 21. Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancer.
    Dickey BL; Nedjai B; Preece MD; Schell MJ; Boulware D; Whiting J; Sirak B; Abrahamsen M; Isaacs-Soriano KA; Kennedy K; Chung CH; Giuliano AR
    Cancer Med; 2022 Oct; 11(20):3735-3742. PubMed ID: 35619332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking and other patient factors in HPV-mediated oropharynx cancer: A retrospective cohort study.
    Schostag K; Lynch PT; Leavitt T; Sumer BD; Yang A; Shah A; Emmet TR; Sher DJ; Day AT
    Am J Otolaryngol; 2022; 43(5):103555. PubMed ID: 36037765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV status and therapeutic initial strategy impact on survival and oncologic outcomes: 5-year results from the multicentric prospective cohort of oropharyngeal cancers Papillophar.
    Culié D; Rousseau A; Pretet JL; Lacau Saint Guily J
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3071-3078. PubMed ID: 34661716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
    Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
    Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
    Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
    Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent prognostic role of human papillomavirus genotype in cervical cancer.
    Hang D; Jia M; Ma H; Zhou J; Feng X; Lyu Z; Yin J; Cui H; Yin Y; Jin G; Hu Z; Shen H; Zhang K; Li N; Dai M
    BMC Infect Dis; 2017 Jun; 17(1):391. PubMed ID: 28583086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic signatures for lineage/sublineage classification of HPV16, 18, 52 and 58 variants.
    Ou Z; Chen Z; Zhao Y; Lu H; Liu W; Li W; Ren P; Geng C; Xiao M; Hu G; Wu D; Wang X; Liu N; Zhu S; Lu L; Li J
    Virology; 2021 Jan; 553():62-69. PubMed ID: 33238224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
    Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
    Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population.
    Evans M; Newcombe R; Fiander A; Powell J; Rolles M; Thavaraj S; Robinson M; Powell N
    BMC Cancer; 2013 May; 13():220. PubMed ID: 23634887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Garset-Zamani M; Carlander AF; Jakobsen KK; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; von Buchwald C
    Int J Cancer; 2022 Apr; 150(7):1174-1183. PubMed ID: 34894151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Prospective Cohort Study of Human Papillomavirus-Driven Oropharyngeal Cancers: Implications for Prognosis and Immunisation.
    Wakeham K; Pan J; Pollock KG; Millan D; Bell S; McLellan D; McPhaden A; Conway DI; Graham SV; Kavanagh K; Cuschieri K
    Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e132-e142. PubMed ID: 31248692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic factors for overall survival in oropharyngeal carcinoma depending on HPV status].
    Riders A; Oberste M; Abbaspour B; Beule A; Rudack C
    HNO; 2022 Feb; 70(2):102-109. PubMed ID: 34170339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
    Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
    J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
    Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M
    Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
    Gillison ML; Koch WM; Capone RB; Spafford M; Westra WH; Wu L; Zahurak ML; Daniel RW; Viglione M; Symer DE; Shah KV; Sidransky D
    J Natl Cancer Inst; 2000 May; 92(9):709-20. PubMed ID: 10793107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oropharyngeal Squamous Cell Carcinoma Morphology and Subtypes by Human Papillomavirus Type and by 16 Lineages and Sublineages.
    Lewis JS; Mirabello L; Liu P; Wang X; Dupont WD; Plummer WD; Pinheiro M; Yeager M; Boland JF; Cullen M; Steinberg M; Bass S; Mehrad M; O'Boyle C; Lin M; Faden DL; Lang-Kuhs KA
    Head Neck Pathol; 2021 Dec; 15(4):1089-1098. PubMed ID: 33797697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.